{"symbol":"LLY","fiscalQuarter":"Q2-2025","reportDate":"2025-08-07","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q2-2025","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Down 14.14%","keyNumbers":[{"metric":"EPS","actual":"$6.31","expected":"N/A","surprise":"+14.08%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Eli Lilly reported a strong EPS that exceeded expectations, but the stock fell significantly by 14.14%. This decline may reflect investor concerns or broader market reactions, as no revenue figures or management commentary were provided to clarify the results.","metaDescription":"Eli Lilly (LLY) Q2 2025 earnings: EPS beat by 14.08%. Stock down 14.14%. Full breakdown."}}